Public Release: 12-May-2015 BMJ Patients should be encouraged to ask if tests are really needed Doctors should discuss potential harms of treatment with patients Experts will develop lists of common practices that should be stopped A US initiative to get… Read More ›
Medical Ethics
Cancer drugs approved quickly but not to patient’s benefit
Public Release: 7-May-2015 Dr. Joel Lexchin cites earlier research reviewing solid cancer drugs within 10 years of EMA approval to point out that these drugs improved survival by just over a month York University TORONTO, May 7, 2015 — Highly… Read More ›
Drug prices to treat multiple sclerosis soar 700% , point to larger problem
Public Release: 24-Apr-2015 Oregon State University PORTLAND, Ore. – A new study released today found that drugs used to treat multiple sclerosis have soared in price in the past two decades, in some cases more than 700 percent, even though… Read More ›
UK doctors unlikely to be able to repay student loans over a lifetime
Public Release: 20-Apr-2015 Clear gender differences in total amounts needed to service debt BMJ UK doctors are unlikely to be able to repay their student loans over the course of their working lives, amassing debts of more than £80,000 by… Read More ›
Science and medicine have a ‘publication pollution’ problem
Public Release: 3-Apr-2015 Dr. Arthur Caplan warns that plagiarism, fraud and predatory publishing is ‘corroding the reliability of research’ NYU Langone Medical Center / New York University School of Medicine (New York, NY) April 3, 2015 – The scientific community… Read More ›
Discontinuing statins for patients with life limiting illness
Public Release: 23-Mar-2015 University of Colorado Denver AURORA, Colo. (March 23, 2015) – Discontinuing statin use in patients with late-stage cancer and other terminal illnesses may help improve patients’ quality of life without causing other adverse health effects, according to… Read More ›
Why people with diabetes can’t buy generic insulin–insulin under patent for more than 90 years.
Public Release: 18-Mar-2015 Drug companies’ incremental changes keep drugs patented, costly, Johns Hopkins study shows Johns Hopkins Medicine Fast Facts Drug companies have made incremental improvements that kept insulin under patent for more than 90 years. Insulin can cost $120… Read More ›
World Health Organization Vaccine Recommendations: Scientific Flaws, or Criminal Misconduct?
Editors Note: ( Ralph Turchiano) The following is from the expert witness Marc Girard, M.D., M.Sc against the alleged vaccine conspiracy and criminal inquiry against the World Health Organization (WHO). At the time of this printing most of the documentation… Read More ›
UCLA researchers for the first time measure the cost of care for a common prostate condition
“The rising cost of health care is unsustainable” Public Release: 10-Mar-2015 Find 400 percent difference between least, most expensive treatments University of California – Los Angeles Health Sciences How much does health care really cost? UCLA researchers have for the… Read More ›
US spends more on cancer care, saves fewer lives than Western Europe
Public Release: 2-Mar-2015 Dartmouth study finds costly US cancer care may provide less value than previously thought Despite sharp increases in spending on cancer treatment, cancer mortality rates in the United States have decreased only modestly since 1970, Samir Soneji,… Read More ›
Your privacy online: Health information at serious risk of abuse
Public Release: 23-Feb-2015 Annenberg research uncovers privacy risks from surfing health web sites University of Pennsylvania Annenberg School for Communication There is a significant risk to your privacy whenever you visit a health-related web page. An analysis of over 80,000… Read More ›
Statin Data Criminally Manipulated to Deceive Doctors
Statin Data Criminally Manipulated to Deceive Doctors = Their paper is an analysis of the data in the statin trials which led them to conclude that “statin advocates have used statistical deception to create the illusion that statins are ‘wonder… Read More ›
Statin drug data criminaly manipulated to show exaggerated benefit and reduced risk?
“This means that only one out of 100 people treated with a statin will have one less heart attack. Statin researchers, however, don’t present the 1% effect to the public. Instead they transform the 1% effect using another statistic, called… Read More ›
Physician guidelines for Googling patients need revisions
Public Release: 2-Feb-2015 With the Internet and social media becoming woven into the modern medical practice, Penn State College of Medicine researchers contend that professional medical societies must update or amend their Internet guidelines to address when it is ethical… Read More ›
Drug makers and the FDA hid from the public Risperdal side effects
PHILADELPHIA (CN) – Regulators failed to act on signs that the popular antipsychotic Risperdal causes teenage boys to grow breasts, a federal complaint from the law firm Sheller PC alleges. Sheller notes in the Jan. 29 action that it represents… Read More ›
Does getting an ‘expensive’ drug affect how much patient benefits?
Public Release: 28-Jan-2015 American Academy of Neurology MINNEAPOLIS – People’s perceptions of the cost of a drug may affect how much they benefit from the drug, even when they are receiving only a placebo, according to a new study of… Read More ›
Rubella vaccination used to induce behavioral problems in children
Psychoneuroendocrinology. 1998 May;23(4):337-51. Influence of socioeconomic status on behavioral, emotional and cognitive effects of rubella vaccination: a prospective, double blind study. – Effects of vaccination with live attenuated Rubella virus on psychological parameters measured in 12-year-old girls with low socioeconomic… Read More ›
Study examines expedited FDA drug approvals, safety questions remain
01 NOV 2013 Fewer patients were studied as part of expedited reviews of new drugs approved by the U.S. Food and Drug Administration (FDA) in 2008 and some safety questions remain unanswered, according to a study published by JAMA Internal… Read More ›
Nearly 7 in 10 Americans Take Prescription Drugs, Mayo Clinic, Olmsted Medical Center Find
Germ fighters, antidepressants, opioids top list; women, elderly likelier to have prescriptions Wednesday, June 19, 2013 ROCHESTER, Minn. — Nearly 70 percent of Americans are on at least one prescription drug, and more than half take two, Mayo Clinic… Read More ›
Over-diagnosis and over-treatment of depression is common in the US
03 MAY 2013 Americans are over-diagnosed and over-treated for depression, according to a new study conducted at the Johns Hopkins Bloomberg School of Public Health. The study examines adults with clinician-identified depression and individuals who experienced major depressive episodes within… Read More ›
You must be logged in to post a comment.